Skip to main content

Shipping expert aligns with NIMASA over development strategy

Shipping expert aligns with NIMASA over development strategy
NIMASA
NIMASA

By Godfrey Bivbere

THE former President of Indigenous Ship-owners Association of Nigeria, ISAN, Isaac Jolapamo, has said that the new management at the Nigerian Maritime Administration and Safety Agency, NIMASA, should focus more on the development of local shipping capacity to help maximise potentials of the sector for the benefit of the nation’s economy.

Earlier last week while briefing the media on his first 100 days in office, the Director General of NIMASA, Dr. Bashir Jamoh, had said that his regime has already prioritised shipping development as one of the three key focus in his three-S strategy. Speaking with Vanguard Maritime Report in Lagos, Jolapamo said regulation and other activities that the agency had been focusing on in the past has benefitted neither the industry nor the nation. He added that the best way to go is to set an annual target of ship acquisition for the country.

The former ISAN boss pointed out the NIMASA can achieve this in two ways; either by direct acquisition or by giving the necessary backing to known ship owners to acquire the much needed asset.

READ ALSOHigh profile Nigerians fly contaminated plane, risk COVID-19 infection

He stressed that it is only in the acquisition of these vessels that regulation can be productive while the foreign ship owners who are desirous to continue operating in the nation will be forced to comply with such regulations.

He noted that the multiplier effect of owning one vessel in terms of revenue and employment can be imagined because it is huge, adding that every ship needs bunkering, chanelling services, dry dock services, employment for sea farers, sea time training of thousands of cadets rooming the streets.

He, therefore, charged the new management of NIMASA to pay more attention to shipping development if they truly want improvement in the sector.

Jamoh had said that NIMASA under him have decided to collapse the agenda of the agency into security, safety and shipping development and has given the agency a “bird’s-eye view of the challenges inherited in our sector.

 

 

The post Shipping expert aligns with NIMASA over development strategy appeared first on Vanguard News.


by Urowayino Jeremiah via Vanguard News https://ift.tt/38kfiZo Best Known Member of the Cabinet Wikipedia

Comments

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...